GT
Greenleaf Trust Portfolio holdings
AUM
$11.3B
1-Year Return
16.87%
This Quarter Return
+8.22%
1 Year Return
+16.87%
3 Year Return
+90.17%
5 Year Return
+122.83%
10 Year Return
+313.46%
AUM
$11.3B
AUM Growth
+$345M
(+3.1%)
Cap. Flow
-$474M
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
78.9%
Holding
853
New
56
Increased
171
Reduced
535
Closed
56
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$41.4M |
| 2 |
TSMC
TSM
|
$5.16M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$3.84M |
| 4 |
SPDR ICE Preferred Securities ETF
PSK
|
$1.21M |
| 5 |
Capital One
COF
|
$1.15M |
Top Sells
| 1 |
Stryker
SYK
|
$169M |
| 2 |
Visa
V
|
$118M |
| 3 |
NVIDIA
NVDA
|
$21.3M |
| 4 |
American Tower
AMT
|
$12.9M |
| 5 |
Apple
AAPL
|
$11.1M |
Sector Composition
| 1 | Healthcare | 59.89% |
| 2 | Technology | 6.36% |
| 3 | Financials | 3.73% |
| 4 | Communication Services | 2.09% |
| 5 | Consumer Discretionary | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Intercontinental Exchange
ICE
$99.7B
| $2.81M | 0.02% |
15,330
-1,187
| -7% | -$218K |
|
152
MetLife
MET
$54.6B
| $2.79M | 0.02% |
34,696
+329
| +1% | +$26.5K |
|
153
iShares MSCI USA Quality Factor ETF
QUAL
$54.6B
| $2.78M | 0.02% |
15,228
-1,416
| -9% | -$259K |
|
154
Hartford Financial Services
HIG
$37.8B
| $2.7M | 0.02% |
21,277
-1,375
| -6% | -$174K |
|
155
Colgate-Palmolive
CL
$68.4B
| $2.7M | 0.02% |
29,669
-876
| -3% | -$79.6K |
|
156
Trane Technologies
TT
$92.3B
| $2.67M | 0.02% |
6,103
-49
| -0.8% | -$21.4K |
|
157
Travelers Companies
TRV
$62.9B
| $2.67M | 0.02% |
9,968
-711
| -7% | -$190K |
|
158
Starbucks
SBUX
$99.1B
| $2.64M | 0.02% |
28,829
-3,716
| -11% | -$340K |
|
159
Hilton Worldwide
HLT
$65.6B
| $2.62M | 0.02% |
9,851
-337
| -3% | -$89.8K |
|
160
Comcast
CMCSA
$125B
| $2.59M | 0.02% |
72,655
-11,656
| -14% | -$416K |
|
161
Sumitomo Mitsui Financial
SMFG
$106B
| $2.57M | 0.02% |
170,092
-356
| -0.2% | -$5.38K |
|
162
Vanguard FTSE Developed Markets ETF
VEA
$172B
| $2.56M | 0.02% |
44,952
+11,109
| +33% | +$633K |
|
163
Gilead Sciences
GILD
$141B
| $2.56M | 0.02% |
23,109
-5,718
| -20% | -$634K |
|
164
Bank of New York Mellon
BK
$73.9B
| $2.55M | 0.02% |
28,009
-1,076
| -4% | -$98K |
|
165
Fifth Third Bancorp
FITB
$30.7B
| $2.54M | 0.02% |
61,795
-3,907
| -6% | -$161K |
|
166
Edwards Lifesciences
EW
$47.8B
| $2.52M | 0.02% |
32,226
-663
| -2% | -$51.9K |
|
167
SS&C Technologies
SSNC
$21.9B
| $2.43M | 0.02% |
29,355
-520
| -2% | -$43.1K |
|
168
Johnson Controls International
JCI
$70.2B
| $2.43M | 0.02% |
22,997
-501
| -2% | -$52.9K |
|
169
Novo Nordisk
NVO
$248B
| $2.39M | 0.02% |
34,675
-754
| -2% | -$52K |
|
170
Broadridge
BR
$29.6B
| $2.39M | 0.02% |
9,832
-171
| -2% | -$41.6K |
|
171
TransDigm Group
TDG
$71.9B
| $2.38M | 0.02% |
1,563
-42
| -3% | -$63.9K |
|
172
CSX Corp
CSX
$60.7B
| $2.37M | 0.02% |
72,539
-3,796
| -5% | -$124K |
|
173
O'Reilly Automotive
ORLY
$88.8B
| $2.35M | 0.02% |
26,121
-2,544
| -9% | -$229K |
|
174
iShares US Treasury Bond ETF
GOVT
$28B
| $2.35M | 0.02% |
102,344
-4,636
| -4% | -$107K |
|
175
Elevance Health
ELV
$70B
| $2.32M | 0.02% |
5,960
-906
| -13% | -$352K |
|